scispace - formally typeset
A

Armin J. Grau

Researcher at Heidelberg University

Publications -  179
Citations -  9170

Armin J. Grau is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Population. The author has an hindex of 45, co-authored 172 publications receiving 8310 citations.

Papers
More filters
Journal ArticleDOI

Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke The German Stroke Data Bank

TL;DR: The results foster the concept of ischemic stroke as a polyetiologic disease with marked differences between subtypes regarding risk factors and outcome, and studies involving risk factors of isChemic stroke should differentiate between etiologic stroke subtypes.
Journal ArticleDOI

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

TL;DR: Among patients with OAC-associated ICH, reversal of anticoagulation reversal and blood pressure (BP) with hematoma enlargement and resumption of OAC therapy was associated with lower risk of ischemic events, and these findings require replication and assessment in prospective studies.
Journal ArticleDOI

Periodontal Disease as a Risk Factor for Ischemic Stroke

TL;DR: periodontitis increased the risk of cerebral ischemia caused by large-artery atherosclerosis, cardioembolism, and cryptogenic etiology, whereas caries was not.
Journal ArticleDOI

Leukocyte Count as an Independent Predictor of Recurrent Ischemic Events

TL;DR: Leukocyte counts and mainly neutrophil counts are independently associated with ischemic events in these high-risk populations, and an increase of leukocytes over baseline levels heralds a period of increased risk lasting about one week.
Journal ArticleDOI

Pathogenesis of cervical artery dissections Association with connective tissue abnormalities

TL;DR: The dermal connective tissue abnormalities detected can serve as a phenotypic marker for further genetic studies in patients with CAD and large families to possibly identify the underlying basic molecular defect(s).